Literature DB >> 16786533

Mutational spectrum of maple syrup urine disease in Spain.

Pilar Rodríguez-Pombo1, Rosa Navarrete, Begoña Merinero, Paulino Gómez-Puertas, Magdalena Ugarte.   

Abstract

Mutations in any of the three different genes BCKDHA, BCKDHB, and DBT encoding for the E1alpha, E1beta, and E2 catalytic components of the branched-chain alpha-ketoacid dehydrogenase (BCKD) complex can cause maple syrup urine disease (MSUD). The disease presents heterogeneous clinical and molecular phenotypes. Severity of the disease ranges from the classical to the mildest variant types. Here, we describe the MSUD genotypes and related phenotypes in a cohort of 33 Spanish patients. Based on complementation testing, we selected 15 patients as defective in E1beta, 10 in E1alpha, seven in E2l; one remains unclassified. 92.5% of alleles have been characterized, and the mutational spectrum includes 36 different sequence variations presumably leading to loss-of-function, 15 changes in the BCKDHA, 14 in the BCKDHB, and seven in the DBT genes. Twenty-four changes are novel. The mutational profile is heterogeneous with no prevalent sequence variations detected, except for the E1beta mutation, c.487G>T (p.Glu163X), which appears on six out of 30 disease alleles analyzed. Approximately 30% of the patients included in this study showed a variant MSUD phenotype. That included 50% of the patients identified as EIa and at least four out of seven of those selected as EII. Precise genotypes as c.[647C>T]+[889C>T] for the EIa and c.[827T>G ]+[1349C>A] for the EII appeared associated to the mildest presentations of the disease. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786533     DOI: 10.1002/humu.9428

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease.

Authors:  Ling Su; Zhikun Lu; Fatao Li; Yongxian Shao; Huiying Sheng; Yanna Cai; Li Liu
Journal:  Metab Brain Dis       Date:  2017-02-15       Impact factor: 3.584

2.  Functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene: understanding a variant presentation of maple syrup urine disease.

Authors:  Paula Fernández-Guerra; Rosa Navarrete; Kara Weisiger; Lourdes R Desviat; Seymour Packman; Magdalena Ugarte; Pilar Rodríguez-Pombo
Journal:  J Inherit Metab Dis       Date:  2010-04-30       Impact factor: 4.982

3.  MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

Authors:  Ailan Cheng; Lianshu Han; Yun Feng; Huimin Li; Rong Yao; Dengbin Wang; Biao Jin
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

4.  Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?

Authors:  Marta Molina Romero; Alberto Yoldi Chaure; Miguel Gañán Parra; Purificación Navas Bastida; José Luis Del Pico Sánchez; Ángel Vaquero Argüelles; Paloma de la Fuente Vaquero; Juan Pablo Ramírez López; José Antonio Castilla Alcalá
Journal:  J Assist Reprod Genet       Date:  2022-01-29       Impact factor: 3.412

5.  Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit.

Authors:  Theodoros Georgiou; Jacinta L Chuang; R Max Wynn; Goula Stylianidou; Mark Korson; David T Chuang; Anthi Drousiotou
Journal:  Genet Test Mol Biomarkers       Date:  2009-10

6.  Description of the mutations in 15 subjects with variant forms of maple syrup urine disease.

Authors:  N Flaschker; O Feyen; S Fend; E Simon; P Schadewaldt; U Wendel
Journal:  J Inherit Metab Dis       Date:  2007-10-08       Impact factor: 4.982

7.  Molecular basis of various forms of maple syrup urine disease in Chilean patients.

Authors:  Diana Ruffato Resende Campanholi; Ana Vitoria Barban Margutti; Wilson A Silva; Daniel F Garcia; Greice A Molfetta; Adriana A Marques; Ida Vanessa Döederlein Schwartz; V Cornejo; Valerie Hamilton; Gabriela Castro; Fernanda Sperb-Ludwig; Ester S Borges; José S Camelo
Journal:  Mol Genet Genomic Med       Date:  2021-05-06       Impact factor: 2.183

8.  Selected reaction monitoring as an effective method for reliable quantification of disease-associated proteins in maple syrup urine disease.

Authors:  Paula Fernández-Guerra; Rune I D Birkler; Begoña Merinero; Magdalena Ugarte; Niels Gregersen; Pilar Rodríguez-Pombo; Peter Bross; Johan Palmfeldt
Journal:  Mol Genet Genomic Med       Date:  2014-06-04       Impact factor: 2.183

9.  Twenty novel mutations in BCKDHA, BCKDHB and DBT genes in a cohort of 52 Saudi Arabian patients with maple syrup urine disease.

Authors:  Faiqa Imtiaz; Abeer Al-Mostafa; Rabab Allam; Khushnooda Ramzan; Nada Al-Tassan; Asma I Tahir; Nouf S Al-Numair; Mohamed H Al-Hamed; Zuhair Al-Hassnan; Mohammad Al-Owain; Hamad Al-Zaidan; Mohammad Al-Amoudi; Alya Qari; Ameera Balobaid; Moeenaldeen Al-Sayed
Journal:  Mol Genet Metab Rep       Date:  2017-04-07

10.  Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population.

Authors:  Ernie Zuraida Ali; Lock-Hock Ngu
Journal:  Mol Genet Metab Rep       Date:  2018-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.